 PARIS and CAMBRIDGE, Mass., Sept. 09, 2021 GLOBE NEWSWIRE -- Biophytis SA NasdaqCM: BPTS, Euronext Growth Paris: ALBPS, a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, today announces the appointment of Rob van Maanen MD MBA as Chief Medical Officer, member of the Executive Committee. 